Literature DB >> 18595766

Molecular pathways of programmed cell death in experimental Parkinson's disease.

Miquel Vila1, Celine Perier.   

Abstract

Dysfunction of mitochondrial complex I leads to degeneration of dopaminergic neurons of the substantia nigra pars compacta, as seen in Parkinson's disease, through activation of mitochondria-dependent programmed cell death pathways. In this scenario, complex I blockade increases the soluble pool of cytochrome c in the mitochondrial intermembrane space through oxidative mechanisms, whereas activation of pro-cell death protein Bax triggers neuronal death by permeabilizing the outer mitochondrial membrane and releasing cytochrome c into the cytosol. Targeting either Bax transcriptional or post-translational activation results in a marked attenuation of dopaminergic cell death caused by complex I inhibition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595766      PMCID: PMC2577905          DOI: 10.1016/j.parkreldis.2008.04.026

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  36 in total

Review 1.  Mitochondrial control of cell death.

Authors:  G Kroemer; J C Reed
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.

Authors:  Simon N Willis; Jamie I Fletcher; Thomas Kaufmann; Mark F van Delft; Lin Chen; Peter E Czabotar; Helen Ierino; Erinna F Lee; W Douglas Fairlie; Philippe Bouillet; Andreas Strasser; Ruth M Kluck; Jerry M Adams; David C S Huang
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

4.  Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Authors:  A Hartmann; P P Michel; J D Troadec; A Mouatt-Prigent; B A Faucheux; M Ruberg; Y Agid; E C Hirsch
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

5.  Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  M Vila; V Jackson-Lewis; S Vukosavic; R Djaldetti; G Liberatore; D Offen; S J Korsmeyer; S Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

7.  The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.

Authors:  J Lotharius; K L O'Malley
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

8.  Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.

Authors:  N A Tatton
Journal:  Exp Neurol       Date:  2000-11       Impact factor: 5.330

9.  JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.

Authors:  Stéphane Hunot; Miquel Vila; Peter Teismann; Roger J Davis; Etienne C Hirsch; Serge Przedborski; Pasko Rakic; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

10.  Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.

Authors:  X G Xia; T Harding; M Weller; A Bieneman; J B Uney; J B Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

View more
  4 in total

Review 1.  Redox dynamics of manganese as a mitochondrial life-death switch.

Authors:  Matthew Ryan Smith; Jolyn Fernandes; Young-Mi Go; Dean P Jones
Journal:  Biochem Biophys Res Commun       Date:  2017-02-03       Impact factor: 3.575

2.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

3.  Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization.

Authors:  Justine Renaud; Julie Bournival; Ximena Zottig; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2013-11-12       Impact factor: 3.911

4.  Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.

Authors:  Emily Filichia; Barry Hoffer; Xin Qi; Yu Luo
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.